Heart rate monitoring to predict nerve damage in diabetes
Part of Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses a Holter monitor to track heart rate changes and autonomic nerve function in people with diabetes, to see if it can predict diabetic autonomic neuropathy. It may help identify early problems and guide therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have signed a consent form to participate.
- You must have a normal heart rhythm (sinus rhythm).
- You must need a Holter ECG for clinical reasons, such as checking for diabetic nerve damage, heart ischemia, or abnormal heart rhythms.
- You must be on stable medications for your condition and not have taken SGLT2 inhibitor drugs before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for blood markers that may help explain or predict heart problems in people who have type 2 diabetes and heart failure. To join, you may also need to be having a planned heart procedure where doctors can collect study information.
This study follows adults with type 2 diabetes to see who may develop heart problems and who may have memory or thinking changes over time. It may help doctors better predict risk and plan earlier support.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This study looks at how the heart uses energy fuel in people with heart failure, including those with type 2 diabetes. It may help researchers understand what’s going on inside the heart and how it could be treated in the future.
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.